Kneller—who specializes in studying HIV protease using crystallography—joined Kovalevsky’s team in January of 2020 to help with the experimental and computational work on the HIV protease.
Microscopic view of the SARS-CoV-2 protease crystals grown in ORNL’s Protein Crystallization and Characterization laboratory.
In general, HIV protease inhibitors are quite effective at blocking protease during HIV replication, but some variations of protease have developed an ability to resist drug inhibitors.
“Figuring out how PRS-17 resists HIV protease inhibitors is a challenge, but one that we absolutely have to overcome.
A drug-resistant type of HIV protease interacting with an HIV protease inhibitor.

Comments to: History of insightful HIV research inspires neutron scattering approach to studying COVID-19

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.

Login

Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.